Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 23
- Q2 2024, −13 vs. previous quarter
- 13F value
- $129.4K
- Reported value at the end of Q2 2024
- Superinvestors holding
- 0
- At the end of Q2 2024
Superinvestors holding SEEL, Q2 2024
No superinvestor reported holding SEEL at the end of Q2 2024.
Latest insider trades
Open-market purchases and sales by Seelos Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 (view filing) | Nov 30 | 1 day | Golembiewski Michael JosephChief Financial Officer | PPurchase | +83.0K | $1.21 | +$100.4K | +2,405.8%86.5K after | |
| Dec 1, 2023 (view filing) | Dec 1 | Same day | Mehra RajSee Remarks | PPurchase | +75.8K | $1.32 | +$100.0K | +69.3%185.1K after | |
| Dec 1, 2023 (view filing) | Dec 1 | Same day | Mehra RajSee Remarks | PPurchase | +75.8K | – | – | –75.8K after | Derivative |
| Jun 2, 2022 (view filing) | Jun 1 | 1 day | O'Connor Daniel J.Director | PPurchase | +16.0K | $0.61 | +$9.76K | New position16.0K after | |
| May 27, 2022 (view filing) | May 26 | 1 day | Dalesandro MargaretDirector | PPurchase | +35.0K | $0.60 | +$21.0K | New position35.0K after | |
| Mar 31, 2022 (view filing) | Mar 31 | Same day | Mehra RajSee Remarks | PPurchase | +66.7K | $0.85 | +$56.7K | +2.1%3.28M after |
Top 10 13F holders, Q2 2024
The largest institutional positions in Seelos Therapeutics, Inc. at the end of Q2 2024; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 89,812 | $55.6K | 0.01% | −372,882−80.6% | Reduced |
| Wealth Effects LLC | 53,844 | $32.1K | 0.01% | −412,816−88.5% | Reduced |
| Morgan Stanley | 22,271 | $13.3K | 0.00% | −103,793−82.3% | Reduced |
| Modera Wealth Management, LLC | 21,336 | $12.7K | 0.00% | −136,281−86.5% | Reduced |
| Geode Capital Management, LLC | 12,797 | $7.64K | 0.00% | −89,611−87.5% | Reduced |
| BlackRock Inc. | 6,975 | $4.16K | 0.00% | −48,986−87.5% | Reduced |
| Tower Research Capital LLC (TRC) | 3,859 | $2.30K | 0.00% | −6,658−63.3% | Reduced |
| Carmichael Hill & Associates, Inc. | 1,000 | $597 | 0.00% | −7,000−87.5% | Reduced |
| JPMorgan Chase & Co | 501 | $300 | 0.00% | −3,531−87.6% | Reduced |
| Bank of America Corp | 472 | $282 | 0.00% | −3,285−87.4% | Reduced |
Holders of 5% or more of SEEL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Seelos Therapeutics, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Weber Mark | 13G | 10.70%46.5K shares | New | Nov 25, 20241 filing | Nov 25, 2024 | SEC |
| Jane Street Group, LLC | 13G | 6.60%38.3K shares | New | Feb 14, 20251 filing | Feb 14, 2025 | SEC |